Literature DB >> 3027606

Benign mitochondrial myopathy with deficiency of NADH-CoQ reductase and cytochrome c oxidase.

A M Roodhooft, K J Van Acker, J J Martin, C Ceuterick, H R Scholte, I E Luyt-Houwen.   

Abstract

Since birth a female child had been weak and hypotonic. At three months of age, head control was lacking; sucking and crying were poor. Four months later, there were more spontaneous movements and the girl was able to push herself up in prone position. Further motor improvement was noted at the age of 15 months. A 25-year-old brother of the patient's mother was very floppy during early childhood and has still some difficulties to swallow. Laboratory work-up showed elevated blood lactate and pyruvate levels, a mild hyperalaninemia and hyperalaninuria and an increased urinary excretion of dicarboxylic acids. Light and electron microscopy of a muscle biopsy disclosed a mitochondria-lipid-glycogen myopathy. Biochemical studies on a second muscle specimen revealed a combined deficiency of NADH-CoQ reductase and cytochrome c oxidase with a low carnitine level. There exists a considerable clinical and biochemical heterogeneity among the myopathies due to disturbances in the mitochondrial respiratory chain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3027606     DOI: 10.1055/s-2008-1052534

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  16 in total

1.  Cytochrome c oxidase deficiency in infancy.

Authors:  A Oldfors; H Sommerland; E Holme; M Tulinius; B Kristiansson
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 2.  Molecular defects of NADH-ubiquinone oxidoreductase (complex I) in mitochondrial diseases.

Authors:  J A Morgan-Hughes; A H Schapira; J M Cooper; J B Clark
Journal:  J Bioenerg Biomembr       Date:  1988-06       Impact factor: 2.945

Review 3.  Reversible infantile mitochondrial diseases.

Authors:  Veronika Boczonadi; Boglarka Bansagi; Rita Horvath
Journal:  J Inherit Metab Dis       Date:  2014-11-19       Impact factor: 4.982

Review 4.  The treatment of congenital lactic acidoses.

Authors:  A A Morris; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

5.  Fatal infantile mitochondrial cardiomyopathy and myopathy with heterogeneous tissue expression of combined respiratory chain deficiencies.

Authors:  J Müller-Höcker; H Ibel; I Paetzke; T Deufel; W Endres; B Kadenbach; J M Gokel; G Hübner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

6.  Biochemical monitoring of the treatment in paediatric patients with mitochondrial disease.

Authors:  R Artuch; M A Vilaseca; M Pineda
Journal:  J Inherit Metab Dis       Date:  1998-12       Impact factor: 4.982

7.  Therapy of complex I deficiency: peripheral neuropathy during dichloroacetate therapy.

Authors:  G Kurlemann; I Paetzke; H Möller; H Masur; G Schuierer; J Weglage; H G Koch
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

8.  Aplasia of the retinal vessels combined with optic nerve hypoplasia, neonatal epileptic seizures, and lactic acidosis due to mitochondrial complex I deficiency.

Authors:  R Boor; R Rochels; B Walther; B Reitter
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

Review 9.  The biochemical basis of mitochondrial diseases.

Authors:  H R Scholte
Journal:  J Bioenerg Biomembr       Date:  1988-04       Impact factor: 2.945

10.  Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy.

Authors:  Rita Horvath; John P Kemp; Helen A L Tuppen; Gavin Hudson; Anders Oldfors; Suely K N Marie; Ali-Reza Moslemi; Serenella Servidei; Elisabeth Holme; Sara Shanske; Gittan Kollberg; Parul Jayakar; Angela Pyle; Harold M Marks; Elke Holinski-Feder; Mena Scavina; Maggie C Walter; Jorida Coku; Andrea Günther-Scholz; Paul M Smith; Robert McFarland; Zofia M A Chrzanowska-Lightowlers; Robert N Lightowlers; Michio Hirano; Hanns Lochmüller; Robert W Taylor; Patrick F Chinnery; Mar Tulinius; Salvatore DiMauro
Journal:  Brain       Date:  2009-08-31       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.